Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
Condition:   Keloid Intervention:   Drug: Dupilumab Sponsors:   Beth Israel Deaconess Medical Center;   Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2021 Category: Research Source Type: clinical trials

Botulinum Toxin Type A Injection to Prevent Keloid Recurrence
Condition:   Scar Keloid Interventions:   Drug: Botulinum Toxin Type A Injection [Botox];   Drug: 0.9% Sodium Chloride Injection Sponsors:   National Cheng-Kung University Hospital;   Tainan Hospital, Ministry of Health and Welfare Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2021 Category: Research Source Type: clinical trials